Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controll... by Xu, Binghe, Prof, Yan, Min, Prof, Ma, Fei, Prof, Hu, Xichun, Prof, Feng, Jifeng, Prof, Ouyang, Quchang, Prof, Tong, Zhongsheng, Prof, Li, Huiping, Prof, Zhang, Qingyuan, Prof, Sun, Tao, Prof, Wang, Xian, MD, Yin, Yongmei, Prof, Cheng, Ying, Prof, Li, Wei, Prof, Gu, Yuanting, Prof, Chen, Qianjun, Prof, Liu, Jinping, Prof, Cheng, Jing, Prof, Geng, Cuizhi, Prof, Qin, Shukui, Prof, Wang, Shusen, Prof, Lu, Jinsong, Prof, Shen, Kunwei, Prof, Liu, Qiang, Prof, Wang, Xiaojia, Prof, Wang, Hong, Prof, Luo, Ting, Prof, Yang, Jin, Prof, Wu, Yudong, Prof, Yu, Zhiyong, Prof, Zhu, Xiaoyu, MD, Chen, Chunxia, MSc, Zou, Jianjun, MD

Get full text

Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial by Jiang, Zefei, Prof, Li, Wei, Prof, Hu, Xichun, Prof, Zhang, Qingyuan, Prof, Sun, Tao, Prof, Cui, Shude, Prof, Wang, Shusen, Prof, Ouyang, Quchang, Prof, Yin, Yongmei, Prof, Geng, Cuizhi, Prof, Tong, Zhongsheng, Prof, Cheng, Ying, Prof, Pan, Yueyin, Prof, Sun, Yuping, MD, Wang, Hong, MD, Ouyang, Tao, Prof, Gu, Kangsheng, Prof, Feng, Jifeng, Prof, Wang, Xiaojia, Prof, Wang, Shubin, Prof, Liu, Tianshu, Prof, Gao, Jinghua, MD, Cristofanilli, Massimo, Prof, Ning, Zhiqiang, MD, Lu, Xianping, PhD

Get full text

Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced br... by Zhang, Pin, Prof, Zhang, Qingyuan, Prof, Tong, Zhongsheng, Prof, Sun, Tao, Prof, Li, Wei, Prof, Ouyang, Quchang, Prof, Hu, Xichun, Prof, Cheng, Ying, Prof, Yan, Min, Prof, Pan, Yueyin, Prof, Teng, Yuee, Prof, Yan, Xi, Prof, Wang, Ying, Prof, Xie, Weimin, Prof, Zeng, Xiaohua, Prof, Wang, Xiaojia, Prof, Hu, Changlu, Prof, Geng, Cuizhi, Prof, Zhang, Hongwei, Prof, Li, Wenxin, Prof, Wu, Xinhong, Prof, Zhong, Jincai, Prof, Xu, Jingwei, Prof, Shi, Yanxia, PhD, Wei, Wenhua, PhD, Bayaxi, Nayima, PhD, Zhu, Xiaoyu, PhD, Xu, Binghe, Prof

Get full text

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 stu... by Swain, Sandra M, Prof, Miles, David, Prof, Kim, Sung-Bae, Prof, Im, Young-Hyuck, Prof, Im, Seock-Ah, Prof, Semiglazov, Vladimir, Prof, Ciruelos, Eva, MD, Schneeweiss, Andreas, Prof, Loi, Sherene, Prof, Monturus, Estefanía, PhD, Clark, Emma, MSc, Knott, Adam, PhD, Restuccia, Eleonora, MD, Benyunes, Mark C, MD, Cortés, Javier, Prof

Get full text